Repertoire Partners’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-100,200
Closed -$1.19M 24
2024
Q2
$1.19M Sell
100,200
-24,200
-19% -$276K 2.25% 7
2024
Q1
$1.49M Buy
124,400
+40,500
+48% +$603K 3.14% 6
2023
Q4
$1.41M Sell
83,900
-56,100
-40% -$794K 2.01% 11
2023
Q3
$2.1M Buy
+140,000
New +$2.36M 3.27% 7
2023
Q2
Sell
-72,689
Closed -$1.3M 26
2023
Q1
$1.3M Sell
72,689
-621,143
-90% -$10.4M 0.38% 19
2022
Q4
$5.78M Buy
+693,832
New +$5.18M 0.58% 15

Other funds holding SHC

Repertoire Partners's SHC Position: Q3 2024 in Review

Repertoire Partners sold out of Sotera Health (SHC) in Q3 2024, closing a stake of 100,200 shares — an estimated $1.19M sold.

Repertoire Partners first reported a position in SHC in Q4 2022 and held it in 6 quarters. The position peaked at $5.78M in Q4 2022. 209 funds tracked by Wall St. Rank hold SHC as of Q3 2024.

  • Repertoire Partners reported no remaining Sotera Health position as of Q3 2024 after selling out during the quarter.
  • Repertoire Partners sold 100,200 Sotera Health shares in Q3 2024, an estimated $1.19M.
  • Repertoire Partners first reported a position in Sotera Health in Q4 2022 and held it in 6 quarters.
  • Repertoire Partners's Sotera Health position peaked at $5.78M in Q4 2022.
  • 209 funds tracked by Wall St. Rank held Sotera Health as of Q3 2024.

Based on Repertoire Partners's 13F filing for Q3 2024, filed 14 Nov 2024.